FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kok van Kessel

Research Profile

Anatomy

Chemicals & Drugs

Living Beings

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
András N Spaan; Kok P M van Kessel; Willemien J M van Rooijen; Piet C Aerts; Cédric Badiou; Carla J C de Haas; Thomas Henry; Johan Kemmink; Gérard Lina; Magali Perret; François Vandenesch; Jos A G van Strijp
The staphylococcal toxin panton-valentine leukocidin targets human c5a receptors.
Robbert Hoogeboom; Arnon P Kater; Roy Reinten; Kok P M van Kessel; Richard Bende; Jeroen E J Guikema; Frans Hochstenbach; Koen Wagner; Thera A Wormhoudt; Carel J M van Noesel
A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi.
András Vida; Attila Bácsi; Bart Bardoel; László Majoros; Fin Milder; Andrea Sümegi; Kok P M van Kessel; Jos A G van Strijp; György Vereb; Péter Antal-Szalmás
Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kok van Kessel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: András N Spaan; Kok P M van Kessel; Willemien J M van Rooijen; Piet C Aerts; Cédric Badiou; Carla J C de Haas; Thomas Henry; Johan Kemmink; Gérard Lina; Magali Perret; François Vandenesch; Jos A G van Strijp
The staphylococcal toxin panton-valentine leukocidin targets human c5a receptors.
Cell host & microbe 2013;13(5):584-94.
2013: Robbert Hoogeboom; Arnon P Kater; Roy Reinten; Kok P M van Kessel; Richard Bende; Jeroen E J Guikema; Frans Hochstenbach; Koen Wagner; Thera A Wormhoudt; Carel J M van Noesel
A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi.
The Journal of experimental medicine 2013;210(1):59-70.
2012: András Vida; Attila Bácsi; Bart Bardoel; László Majoros; Fin Milder; Andrea Sümegi; Kok P M van Kessel; Jos A G van Strijp; György Vereb; Péter Antal-Szalmás
Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils.
Immunology letters 2012;146(1-2):31-9.
2012: Alexander J Laarman; Cheryl L Malone; Gerdien Mijnheer; Graeme Milligan; Joe M Mootz; Maartje Ruyken; Kok P M van Kessel; Willemien J M van Rooijen; Jos A G van Strijp; Richard Ward; Carla J C de Haas; Erik C Heezius; Alexander R Horswill; Suzan H M Rooijakkers
Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis.
The EMBO journal 2012;31(17):3607-19.
2012: Bart W Bardoel; Carla J C de Haas; Dennis Hartsink; Jos A G van Strijp; Mignon M Vughs; Kok P M van Kessel
Identification of an immunomodulating metalloprotease of Pseudomonas aeruginosa (IMPa).
Cellular microbiology 2012;14(6):902-13.
2012: Bart W Bardoel; Kok P M van Kessel; Jos A G van Strijp; Fin J Milder
Inhibition of Pseudomonas aeruginosa virulence: characterization of the AprA-AprI interface and species selectivity.
Journal of molecular biology 2012;415(3):573-83.
2011: András Vida; André F M Verheul; Jan Verhoef; Péter Antal-Szalmás; Annet Troelstra; Toon J P van Bommel; Kok P M van Kessel; Jos A G van Strijp
Neutralization of Neisseria meningitidis outer membrane vesicles.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2011;60(9):801-5.
2011: Bart W Bardoel; Michiel J C Pel; Corné M J Pieterse; Jan Tommassen; Sjoerd van der Ent; Kok P M van Kessel; Jos A G van Strijp
Pseudomonas evades immune recognition of flagellin in both mammals and plants.
PLoS pathogens 2011;7(8):e1002206.
2010: Erika Gustafsson; Anna Rosén; Karin Barchan; Kok P M van Kessel; Karin Haraldsson; Stina Lindman; Cecilia Forsberg; Lill Ljung; Karin Bryder; Björn Walse; Pieter-Jan Haas; Jos A G van Strijp; Christina Furebring
Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies.
Protein engineering, design & selection : PEDS 2010;23(2):91-101.
2009: Cristina Prat; Pieter-Jan Haas; Jovanka Bestebroer; Carla J C de Haas; Jos A G van Strijp; Kok P M van Kessel
A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(10):6569-78.
2009: Jovanka Bestebroer; Kok P M van Kessel; Hafida Azouagh; Annemiek M Walenkamp; Ingrid G J Boer; Roland A Romijn; Jos A G van Strijp; Carla J C de Haas
Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins.
Blood 2009;113(2):328-37.
2009: Armand Paauw; Maurine A Leverstein-van Hall; Kok P M van Kessel; Jan Verhoef; Ad C Fluit
Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells.
PloS one 2009;4(12):e8240.
2008: Jimmy F P Berbée; Caroline C van der Hoogt; Carla J C de Haas; Kok P M van Kessel; Geesje M Dallinga-Thie; Johannes A Romijn; Louis M Havekes; Henk J van Leeuwen; Patrick C N Rensen
Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis.
Intensive care medicine 2008;34(5):907-11.
2007: Ilse Jongerius; Jörg Köhl; Manoj Pandey; Maartje Ruyken; Kok P M van Kessel; Jos van Strijp; Suzan H M Rooijakkers
Staphylococcal complement evasion by various convertase-blocking molecules.
The Journal of experimental medicine 2007;204(10):2461-71.
2007: Bart E van Ewijk; Tom F W Wolfs; Piet C Aerts; Kok P M van Kessel; André Fleer; Jan L L Kimpen; Cornelis K van der Ent
RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells.
Pediatric research 2007;61(4):398-403.
2007: Jovanka Bestebroer; Miriam J J G Poppelier; Laurien H Ulfman; Peter J Lenting; Cécile V Denis; Kok P M van Kessel; Jos van Strijp; Carla J C de Haas
Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling.
Blood 2007;109(7):2936-43.
2006: Cristina Prat; Jovanka Bestebroer; Carla J C de Haas; Jos van Strijp; Kok P M van Kessel
A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(11):8017-26.
2006: Suzan H M Rooijakkers; Maartje Ruyken; Jos van Roon; Kok P M van Kessel; Jos van Strijp; Willem J B Van Wamel
Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus.
Cellular microbiology 2006;8(8):1282-93.
2006: Judy Higgins; Anthony Loughman; Kok P M van Kessel; Jos van Strijp; Timothy J Foster
Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
FEMS microbiology letters 2006;258(2):290-6.
2006: Antonie J H H M van Oostrom; H W M Plokker; B Sweder van Asbeck; ton rabelink; Kok P M van Kessel; E H J M Jansen; C D A Stehouwer; M Castro Cabezas
Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis.
Atherosclerosis 2006;185(2):331-9.
2006: Willem J B Van Wamel; Suzan H M Rooijakkers; Maartje Ruyken; Kok P M van Kessel; Jos van Strijp
The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.
Journal of bacteriology 2006;188(4):1310-5.
2006: Manuela Dürr; Sascha Kristian; Michael Otto; Gianluca Matteoli; Peter S Margolis; Joaquim Trias; Kok P M van Kessel; Jos van Strijp; Erwin Bohn; Regine Landmann; Andreas Peschel
Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus.
Cellular microbiology 2006;8(2):207-17.
2005: Suzan H M Rooijakkers; Kok P M van Kessel; Jos van Strijp
Staphylococcal innate immune evasion.
Trends in microbiology 2005;13(12):596-601.
2005: Pieter-Jan Haas; Carla J C de Haas; Miriam J J G Poppelier; Kok P M van Kessel; Jos van Strijp; Klaas Dijkstra; Ruud M Scheek; Hao Fan; John A W Kruijtzer; Rob M J Liskamp; Johan Kemmink
The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.
Journal of molecular biology 2005;353(4):859-72.
2005: Suzan H M Rooijakkers; Maartje Ruyken; Anja Roos; Mohamed R Daha; Julia S Presanis; Robert B Sim; Willem J B Van Wamel; Kok P M van Kessel; Jos van Strijp
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
Nature immunology 2005;6(9):920-7.
2005: Henk J van Leeuwen; M Van Der Tol; Jos van Strijp; Jan Verhoef; Kok P M van Kessel
The role of tumour necrosis factor in the kinetics of lipopolysaccharide-mediated neutrophil priming in whole blood.
Clinical and experimental immunology 2005;140(1):65-72.
2005: Suzan H M Rooijakkers; Willem J B Van Wamel; Maartje Ruyken; Kok P M van Kessel; Jos van Strijp
Anti-opsonic properties of staphylokinase.
Microbes and infection / Institut Pasteur 2005;7(3):476-84.
2005: Bent Postma; Wendy Kleibeuker; Miriam J J G Poppelier; Miranda Boonstra; Kok P M van Kessel; Jos van Strijp; Carla J C de Haas
Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.
The Journal of biological chemistry 2005;280(3):2020-7.
2005: Michiel van der Flier; Henk J van Leeuwen; Kok P M van Kessel; Jan L L Kimpen; Andy I M Hoepelman; S P M Geelen
Plasma vascular endothelial growth factor in severe sepsis.
Shock (Augusta, Ga.) 2005;23(1):35-8.
2004: Pieter-Jan Haas; Carla J C de Haas; Wendy Kleibeuker; Miriam J J G Poppelier; Kok P M van Kessel; John A W Kruijtzer; Rob M J Liskamp; Jos van Strijp
N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(9):5704-11.
2004: Bent Postma; Miriam J J G Poppelier; Joost van Galen; Eric R Prossnitz; Jos van Strijp; Carla J C de Haas; Kok P M van Kessel
Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):6994-7001.
2004: Péter Antal-Szalmás; Miriam J J G Poppelier; Andrea Sümegi; Tjomme van der Bruggen; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations.
Immunology letters 2004;93(1):11-5.
2004: Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M van Kessel; Jos van Strijp
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
The Journal of experimental medicine 2004;199(5):687-95.
2003: Jaklien C Leemans; Mirjam Heikens; Kok P M van Kessel; Sandrine Florquin; Tom van der Poll
Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice.
Clinical and diagnostic laboratory immunology 2003;10(5):950-3.
2003: Henk J van Leeuwen; Eric C J M Heezius; Geesje M Dallinga; Jos van Strijp; Jan Verhoef; Kok P M van Kessel
Lipoprotein metabolism in patients with severe sepsis.
Critical care medicine 2003;31(5):1359-66.
2003: Sonja Von Aulock; Siegfried Morath; Lars Hareng; Sylvia Knapp; Kok P M van Kessel; Jos van Strijp; Thomas Hartung
Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment.
Immunobiology 2003;208(4):413-22.
2003: Kok P M van Kessel; Karin Ellen Veldkamp; Andreas Pesschel; Carla J C de Haas; Jan Verhoef; Jos van Strijp
Tips and tricks from Staphylococcus aureus.
Advances in experimental medicine and biology 2003;531():341-9.
2002: L Vincent Collins; Sascha Kristian; Christopher Weidenmaier; Marion Faigle; Kok P M van Kessel; Jos van Strijp; Friedrich Götz; Birgid Neumeister; Andreas Peschel
Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.
The Journal of infectious diseases 2002;186(2):214-9.
2002: Jaklien C Leemans; Margriet J Vervoordeldonk; Sandrine Florquin; Kok P M van Kessel; Tom van der Poll
Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus.
American journal of respiratory and critical care medicine 2002;165(10):1445-50.
2001: Péter Antal-Szalmás; I Szöllosi; Gabriella Lakos; Emese Kiss; István Csípo; Andrea Sümegi; Sándor Sipka; Jos van Strijp; Kok P M van Kessel; Gyula Szegedi
A novel flow cytometric assay to quantify soluble CD14 concentration in human serum.
Cytometry 2001;45(2):115-23.
2001: Henk J van Leeuwen; André P Van Beek; Geesje M Dallinga-Thie; Jos van Strijp; Jan Verhoef; Kok P M van Kessel
The role of high density lipoprotein in sepsis.
The Netherlands journal of medicine 2001;59(3):102-10.
2001: Andreas Peschel; Ralph W Jack; Michael Otto; L Vincent Collins; Petra Staubitz; G Nicholson; Hubert Kalbacher; Willem F Nieuwenhuizen; Günther Jung; A Tarkowski; Kok P M van Kessel; Jos van Strijp
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.
The Journal of experimental medicine 2001;193(9):1067-76.
2000: Péter Antal-Szalmás; Miriam J J G Poppelier; Roel Broekhuizen; Jan Verhoef; Jos van Strijp; Kok P M van Kessel
Diverging pathways for lipopolysaccharide and CD14 in human monocytes.
Cytometry 2000;41(4):279-88.
2000: Karin Ellen Veldkamp; H C Heezius; Jan Verhoef; Jos van Strijp; Kok P M van Kessel
Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate.
Infection and immunity 2000;68(10):5908-13.
2000: Carla J C de Haas; Miriam J J G Poppelier; Kok P M van Kessel; Jos van Strijp
Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide.
Infection and immunity 2000;68(9):4954-60.
2000: Carla J C de Haas; Henk J van Leeuwen; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS.
Journal of immunological methods 2000;242(1-2):79-89.
2000: Carla J C de Haas; E M van Leeuwen; Toon van Bommel; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.
Infection and immunity 2000;68(4):1753-9.
1999: Carla J C de Haas; R van der Zee; Barry Benaissa-Trouw; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS.
Infection and immunity 1999;67(6):2790-6.
1999: Annet Troelstra; LA de Graaf-Miltenburg; Toon van Bommel; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):4220-5.
1998: Carla J C de Haas; Pieter-Jan Haas; Kok P M van Kessel; Jos van Strijp
Affinities of different proteins and peptides for lipopolysaccharide as determined by biosensor technology.
Biochemical and biophysical research communications 1998;252(2):492-6.
1998: Carla J C de Haas; M E van der Tol; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3607-15.
1997: WN Hustinx; Barry Benaissa-Trouw; Kok P M van Kessel; J Kuenen; L Tavares; Kees Kraaijeveld; Jan Verhoef; A Hoepelman
Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis.
European journal of clinical investigation 1997;27(12):1044-8.
1997: Franz-Josef Schmitz; Karin Ellen Veldkamp; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst.
The Journal of infectious diseases 1997;176(6):1531-7.
1997: Karin Ellen Veldkamp; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Staphylococcal culture supernates stimulate human phagocytes.
Inflammation 1997;21(5):541-51.
1997: M A Wisselink; Kok P M van Kessel; Ton Willemse
Leukocyte mobilization to skin lesions, determination of cell surface receptors (CD11b/CD18) and phagocytic capacities of neutrophils in dogs with chronic deep pyoderma.
Veterinary immunology and immunopathology 1997;57(3-4):179-86.
1997: P Antal-Szalmas; J A Strijp; Annemarie J L Weersink; Jan Verhoef; Kok P M van Kessel
Quantitation of surface CD14 on human monocytes and neutrophils.
Journal of leukocyte biology 1997;61(6):721-8.
1997: Annet Troelstra; P Antal-Szalmas; LA de Graaf-Miltenburg; Annemarie J L Weersink; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes.
Infection and immunity 1997;65(6):2272-7.
1997: Annet Troelstra; B N Giepmans; Kok P M van Kessel; H S Lichenstein; Jan Verhoef; Jos van Strijp
Dual effects of soluble CD14 on LPS priming of neutrophils.
Journal of leukocyte biology 1997;61(2):173-8.
1996: H Frasa; Barry Benaissa-Trouw; L Tavares; Kok P M van Kessel; W Hustinx; J Schellekens; K Kraaijeveld; Jan Verhoef
Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.
Antimicrobial agents and chemotherapy 1996;40(4):999-1004.
1996: H Frasa; Barry Benaissa-Trouw; L Tavares; Kok P M van Kessel; M Poppelier; K Kraaijeveld; Jan Verhoef
Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.
Infection and immunity 1996;64(3):775-81.
1996: E Mattsson; H Van Dijk; Kok P M van Kessel; Jan Verhoef; André Fleer; J Rollof
Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar.
The Journal of infectious diseases 1996;173(1):212-8.
1995: Kok P M van Kessel; Annemarie J L Weersink; M E Van der Tol; Jan Verhoef
Stimulated human neutrophils release intact BPI without a concomitant change in expression on the cell surface.
Progress in clinical and biological research 1995;392():305-15.
1994: Annemarie J L Weersink; Kok P M van Kessel; M E Van der Tol; Jan Verhoef
Modulation of lipopolysaccharide binding to human granulocytes.
Immunology 1994;83(4):617-23.
1994: P M Schneeberger; P van Langevelde; Kok P M van Kessel; Christina M.J.E, Vandenbroucke-Grauls; Jan Verhoef
Lipopolysaccharide induces hyperadhesion of endothelial cells for neutrophils leading to damage.
Shock (Augusta, Ga.) 1994;2(4):296-300.
1993: I Corrales; Annemarie J L Weersink; Jan Verhoef; Kok P M van Kessel
Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.
Immunology 1993;80(1):84-9.
1993: Annemarie J L Weersink; Kok P M van Kessel; M E van den Tol; Jos van Strijp; Ruurd Torensma; Jan Verhoef; P Elsbach; J Weiss
Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(1):253-63.
1991: Kok P M van Kessel; Jos van Strijp; Jan Verhoef
Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(11):3862-8.
1991: Jos van Strijp; M E van der Tol; L A Miltenburg; Kok P M van Kessel; Jan Verhoef
Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.
Immunology 1991;73(1):77-82.
1990: Kok P M van Kessel; Jos van Strijp; H J van Kats-Renaud; L A Miltenburg; Ad C Fluit; Jan Verhoef
Uncoupling of oxidative and non-oxidative mechanisms in human granulocyte-mediated cytotoxicity: use of cytoplasts and cells from chronic granulomatous disease patient.
Journal of leukocyte biology 1990;48(4):359-66.
1990: Annemarie J L Weersink; Kok P M van Kessel; Ruurd Torensma; Jos van Strijp; Jan Verhoef
Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(1):318-24.
1990: Jos van Strijp; L A Miltenburg; M E van der Tol; Kok P M van Kessel; Ad C Fluit; Jan Verhoef
Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes.
The Journal of general virology 1990;71 ( Pt 5)():1205-9.
1990: Kok P M van Kessel; J Verhoef
A view to a kill: cytotoxic mechanisms of human polymorphonuclear leukocytes compared with monocytes and natural killer cells.
Pathobiology : journal of immunopathology, molecular and cellular biology 1990;58(5):249-64.
1989: Kok P M van Kessel; Jos van Strijp; M E van der Tol; H J van Kats-Renaud; R M Thijssen; Ad C Fluit; Jan Verhoef
Quantitation of conjugate formation between human polymorphonuclear leukocytes and antibody-coated target cells by flow cytometry: the role of Fc receptor and LFA-1 antigen.
Journal of leukocyte biology 1989;46(5):467-75.
1989: Jos van Strijp; Kok P M van Kessel; M E van der Tol; Jan Verhoef
Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.
The Journal of clinical investigation 1989;84(1):107-12.
1989: Kok P M van Kessel; Jos van Strijp; L M Miltenburg; H J Van Kats-Renaud; Ad C Fluit; Jan Verhoef
Antibody-coated target cell membrane-induced chemiluminescence by human polymorphonuclear leukocytes.
Journal of immunological methods 1989;118(2):279-85.
1989: Jos van Strijp; Kok P M van Kessel; M E van der Tol; Ad C Fluit; Harm Snippe; Jan Verhoef
Phagocytosis of herpes simplex virus by human granulocytes and monocytes.
Archives of virology 1989;104(3-4):287-98.
1988: L A Hart; P van Enckevort; Kok P M van Kessel; H van Dijk; R P Labadie
Evidence that superoxide-anion, produced by PMA-activated human polymorphonuclear leukocytes, is the cytolytic agent for rabbit, but not for sheep red blood cells.
Immunology letters 1988;18(2):139-44.
1988: Jos van Strijp; Kok P M van Kessel; L A Miltenburg; Ad C Fluit; Jan Verhoef
Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.
Journal of virology 1988;62(3):847-50.
1987: Kok P M van Kessel; Jos van Strijp; H J Van Kats-Renaud; L A Miltenburg; M E Van Der Tol; Ad C Fluit; Jan Verhoef
Further evidence against a role for toxic oxygen products as lytic agents in NK cell-mediated cytotoxicity.
Immunology 1987;62(4):675-8.
1986: Kok P M van Kessel; Maarten R Visser; Jos van Strijp; J H van Kats-Renaud; J Verhoef
Cytotoxicity by human adherent cells: oxygen-dependent and -independent cytotoxic reactions by different cell populations.
Immunology 1986;58(2):291-6.
1986: Kok P M van Kessel; H J Van Kats-Renaud; Jos van Strijp; Maarten R Visser; Jan Verhoef
Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.
Journal of immunological methods 1986;88(1):101-7.